ASeq Newsletter

ASeq Newsletter

Rose Diagnostics

May 14, 2026
∙ Paid

The Rose diagnostic instrument is designed to validate the quality of cancer biopsies at point-of-care. It uses a lateral flow strip and existing readout device. They raised $2.3M in 2025.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2026 Nava Whiteford · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture